Literature DB >> 18221068

The efficacy of caelyx and hyperthermia for anticancer treatment.

Vasilios E Kouloulias1, Georgios V Koukourakis, Aristides K Petridis, Ioannis Kouvaris, Athanasios D Gouliamos.   

Abstract

The efficacy of hyperthermia and caelyx as single modalities of therapy in progressed and refractory cancer of different primary sites is well known. Nevertheless, it remains question mark whether they can work together to that direction. We have recently published a paper which demonstrates some excellent results in treatment of recurrent breast cancer with hyperthermia in conjunction with caelyx and radiotherapy. The mechanism of action of those different therapeutic options and a review in literature are presented in this paper. Despite the limited number of studies, they all show that the combined treatment is effective and well tolerated. It would be interesting to mention another treatment patent of cancer which can be done by a combination of non-ionizing radiation and androgen deprivation. Also, combined therapy for tumors and tumor metastases comprised administration of integrin ligands and co-therapeutic agents have synergistic efficacy in isolated organ perfusion. Finally, the treatment of solid tumors can be done by glycolytic inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18221068     DOI: 10.2174/157489207782497208

Source DB:  PubMed          Journal:  Recent Pat Anticancer Drug Discov        ISSN: 1574-8928            Impact factor:   4.169


  1 in total

Review 1.  Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data.

Authors:  Timothy M Zagar; James R Oleson; Zeljko Vujaskovic; Mark W Dewhirst; Oana I Craciunescu; Kimberly L Blackwell; Leonard R Prosnitz; Ellen L Jones
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.